aTyr Pharma

Performance

About aTyr Pharma

aTyr Pharma is a biotechnology company focused on translating extracellular tRNA synthetase biology into therapies for fibrosis and inflammatory diseases. The company develops first-in-class approaches targeting fibrotic and inflammatory conditions, with programs and clinical efforts such as Efzofitimod and other research initiatives. Its operations and development activities are centered in the United States, with a science emphasis on translating tRNA synthetase biology into novel medicines for diseases like pulmonary sarcoidosis and interstitial lung disease.